Neuro20 Technologies Corp.

Neuro20 Technologies Corp. manufactures FDA-cleared wearable neuromuscular electrical stimulation (EMS) systems designed for rehabilitation, physical therapy, and movement recovery. Their core product is the Neuro20 Smart Suit, a full-body wearable system paired with the Neuro20 PRO software and Control Box. The platform delivers customized electrical stimulation to individual muscle groups, enabling simultaneous multi-channel stimulation that the company claims cannot be replicated by conventional EMS devices. Applications include neurological conditions (multiple sclerosis, stroke, long COVID, spinal cord injury, Parkinson's, ALS, Guillain-Barré), orthopedic rehabilitation, chronic pain management, post-surgical recovery, and sports/fitness performance. The system is designed for both clinical use and home therapy. Key therapeutic benefits claimed include increased muscle strength and range of motion, improved blood circulation and synovial fluid, enhanced lymphatic drainage, reduced muscle spasms and atrophy, pain relief, and muscle re-education for dormant or paralyzed muscle groups. The device is non-invasive, drug-free, and portable. Neuro20 serves patients, medical providers (physical therapists, chiropractors, primary care), and research institutions. The company markets globally and provides clinical support, training, and ongoing research collaboration.